FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Name: Work Video:
Duration: 3 min 30 s
Description: Learning Objectives After completing this course, the reader will be able to: Add vorinostat to the armamentarium of drugs for CTCL.Identify the mechanism of action of vorinostat.Identify goals of therapy of CTCL.Identify active CTCL therapies.Identify CTCL response criteria. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Bhupinder Mann; John R. Johnson; Martin H. Cohen; Robert Justice; Richard Pazdur
{'id': 'https://openalex.org/W2149379768', 'doi': 'https://doi.org/10.1634/theoncologist.12-10-1247', 'title': 'FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma', 'display_name': 'FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma', 'publication_year': 2007, 'publication_date': '2007-10-01', 'ids': {'openalex': 'https://openalex.org/W2149379768', 'doi': 'https://doi.org/10.1634/theoncologist.12-10-1247', 'mag': '2149379768', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17962618'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.12-10-1247', 'pdf_url': 'https://academic.oup.com/oncolo/article-pdf/12/10/1247/41835622/oncolo_12_10_1247.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://academic.oup.com/oncolo/article-pdf/12/10/1247/41835622/oncolo_12_10_1247.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5021294612', 'display_name': 'Bhupinder Mann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Bhupinder S. Mann', 'raw_affiliation_strings': ['Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070547422', 'display_name': 'John R. Johnson', 'orcid': 'https://orcid.org/0000-0002-3920-9923'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John R. Johnson', 'raw_affiliation_strings': ['Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110048437', 'display_name': 'Martin H. Cohen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Martin H. Cohen', 'raw_affiliation_strings': ['Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040994580', 'display_name': 'Robert Justice', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert Justice', 'raw_affiliation_strings': ['Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051520990', 'display_name': 'Richard Pazdur', 'orcid': 'https://orcid.org/0000-0002-4771-9923'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Pazdur', 'raw_affiliation_strings': ['Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5021294612'], 'corresponding_institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070'], 'apc_list': {'value': 3494, 'currency': 'USD', 'value_usd': 3494, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 17.841, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 1213, 'citation_normalized_percentile': {'value': 0.925047, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '12', 'issue': '10', 'first_page': '1247', 'last_page': '1252'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11811', 'display_name': 'Cutaneous lymphoproliferative disorders research', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9952, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vorinostat', 'display_name': 'Vorinostat', 'score': 0.9323243}, {'id': 'https://openalex.org/keywords/cutaneous-t-cell-lymphoma', 'display_name': 'Cutaneous T-cell lymphoma', 'score': 0.5489349}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.93511444}, {'id': 'https://openalex.org/C2776262904', 'wikidata': 'https://www.wikidata.org/wiki/Q905901', 'display_name': 'Vorinostat', 'level': 5, 'score': 0.9323243}, {'id': 'https://openalex.org/C2776780870', 'wikidata': 'https://www.wikidata.org/wiki/Q5196687', 'display_name': 'Cutaneous T-cell lymphoma', 'level': 4, 'score': 0.5489349}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.43262467}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.35053253}, {'id': 'https://openalex.org/C2777756187', 'wikidata': 'https://www.wikidata.org/wiki/Q1891209', 'display_name': 'Mycosis fungoides', 'level': 3, 'score': 0.3012938}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.23001102}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C2778305200', 'wikidata': 'https://www.wikidata.org/wiki/Q174378', 'display_name': 'Histone deacetylase', 'level': 4, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D056572', 'descriptor_name': 'Histone Deacetylase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D016410', 'descriptor_name': 'Lymphoma, T-Cell, Cutaneous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020714', 'descriptor_name': 'Maximum Tolerated Dose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009367', 'descriptor_name': 'Neoplasm Staging', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016879', 'descriptor_name': 'Salvage Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015996', 'descriptor_name': 'Survival Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077337', 'descriptor_name': 'Vorinostat', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.12-10-1247', 'pdf_url': 'https://academic.oup.com/oncolo/article-pdf/12/10/1247/41835622/oncolo_12_10_1247.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17962618', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.12-10-1247', 'pdf_url': 'https://academic.oup.com/oncolo/article-pdf/12/10/1247/41835622/oncolo_12_10_1247.pdf', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 19, 'referenced_works': ['https://openalex.org/W1895474562', 'https://openalex.org/W1967018540', 'https://openalex.org/W2009121506', 'https://openalex.org/W2030822086', 'https://openalex.org/W2052181006', 'https://openalex.org/W2061352751', 'https://openalex.org/W2071115015', 'https://openalex.org/W2086384126', 'https://openalex.org/W2099803844', 'https://openalex.org/W2107040737', 'https://openalex.org/W2110957729', 'https://openalex.org/W2112906780', 'https://openalex.org/W2115782311', 'https://openalex.org/W2135619784', 'https://openalex.org/W2143662019', 'https://openalex.org/W2169409181', 'https://openalex.org/W2286640581', 'https://openalex.org/W2502134830', 'https://openalex.org/W4238675883'], 'related_works': ['https://openalex.org/W4384937526', 'https://openalex.org/W3036874251', 'https://openalex.org/W2976440729', 'https://openalex.org/W2975546699', 'https://openalex.org/W2341431457', 'https://openalex.org/W2124260720', 'https://openalex.org/W2107646176', 'https://openalex.org/W2066492344', 'https://openalex.org/W2017418416', 'https://openalex.org/W1982714275'], 'abstract_inverted_index': {'Learning': [0], 'Objectives': [1], 'After': [2], 'completing': [3], 'this': [4], 'course,': [5], 'the': [6, 15, 21, 41], 'reader': [7], 'will': [8], 'be': [9], 'able': [10], 'to:': [11], 'Add': [12], 'vorinostat': [13], 'to': [14], 'armamentarium': [16], 'of': [17, 23, 25, 28, 30], 'drugs': [18], 'for': [19], 'CTCL.Identify': [20, 31], 'mechanism': [22], 'action': [24], 'vorinostat.Identify': [26], 'goals': [27], 'therapy': [29], 'active': [32], 'CTCL': [33, 35], 'therapies.Identify': [34], 'response': [36], 'criteria.': [37], 'Access': [38], 'and': [39, 45], 'take': [40], 'CME': [42], 'test': [43], 'online': [44], 'receive': [46], '1': [47, 51], 'AMA': [48], 'PRA': [49], 'Category': [50], 'Credit™': [52], 'at': [53], 'CME.TheOncologist.com': [54]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2149379768', 'counts_by_year': [{'year': 2024, 'cited_by_count': 43}, {'year': 2023, 'cited_by_count': 80}, {'year': 2022, 'cited_by_count': 70}, {'year': 2021, 'cited_by_count': 102}, {'year': 2020, 'cited_by_count': 107}, {'year': 2019, 'cited_by_count': 95}, {'year': 2018, 'cited_by_count': 85}, {'year': 2017, 'cited_by_count': 85}, {'year': 2016, 'cited_by_count': 77}, {'year': 2015, 'cited_by_count': 64}, {'year': 2014, 'cited_by_count': 72}, {'year': 2013, 'cited_by_count': 73}, {'year': 2012, 'cited_by_count': 68}], 'updated_date': '2024-12-20T01:25:05.967498', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
